Adze Biotechnology

Coral Gables, United States

Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers.

$6.2M raised

Mar 2023

Series A

Biotechnology Health Care Medical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Adze Biotechnology

How much funding has Adze Biotechnology raised?

Adze Biotechnology has raised $6.2M in total funding. The most recent round was Series A. The last funding was announced in March 2023.

Where is Adze Biotechnology headquartered?

Adze Biotechnology is headquartered in Coral Gables, United States.

What does Adze Biotechnology do?

Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers.

What stage is Adze Biotechnology at?

Adze Biotechnology is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 14, 2023.

MLA

"Adze Biotechnology — Funding & Investors." VCBacked, March 14, 2023, https://www.vcbacked.co/company/adze-biotechnology. Accessed July 2, 2026.

APA

VCBacked. (2023). Adze Biotechnology — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/adze-biotechnology

Wikipedia (cite web)

{{cite web |title=Adze Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/adze-biotechnology |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 14, 2023.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K